OBJECTIVE: The anticipation of adverse outcomes, or worry, is a cardinal symptom of generalized anxiety disorder. Prior work with healthy subjects has shown that anticipating aversive events recruits a network of brain regions, including the amygdala and anterior cingulate cortex. This study tested whether patients with generalized anxiety disorder have alterations in anticipatory amygdala function and whether anticipatory activity in the anterior cingulate cortex predicts treatment response. METHOD: Functional magnetic resonance imaging (fMRI) was employed with 14 generalized anxiety disorder patients and 12 healthy comparison subjects matched for age, sex, and education. The event-related fMRI paradigm was composed of one warning cue that preceded aversive pictures and a second cue that preceded neutral pictures. Following the fMRI session, patients received 8 weeks of treatment with extended-release venlafaxine. RESULTS: Patients with generalized anxiety disorder showed greater anticipatory activity than healthy comparison subjects in the bilateral dorsal amygdala preceding both aversive and neutral pictures. Building on prior reports of pretreatment anterior cingulate cortex activity predicting treatment response, anticipatory activity in that area was associated with clinical outcome 8 weeks later following treatment with venlafaxine. Higher levels of pretreatment anterior cingulate cortex activity in anticipation of both aversive and neutral pictures were associated with greater reductions in anxiety and worry symptoms. CONCLUSIONS: These findings of heightened and indiscriminate amygdala responses to anticipatory signals in generalized anxiety disorder and of anterior cingulate cortex associations with treatment response provide neurobiological support for the role of anticipatory processes in the pathophysiology of generalized anxiety disorder.
OBJECTIVE: The anticipation of adverse outcomes, or worry, is a cardinal symptom of generalized anxiety disorder. Prior work with healthy subjects has shown that anticipating aversive events recruits a network of brain regions, including the amygdala and anterior cingulate cortex. This study tested whether patients with generalized anxiety disorder have alterations in anticipatory amygdala function and whether anticipatory activity in the anterior cingulate cortex predicts treatment response. METHOD: Functional magnetic resonance imaging (fMRI) was employed with 14 generalized anxiety disorderpatients and 12 healthy comparison subjects matched for age, sex, and education. The event-related fMRI paradigm was composed of one warning cue that preceded aversive pictures and a second cue that preceded neutral pictures. Following the fMRI session, patients received 8 weeks of treatment with extended-release venlafaxine. RESULTS:Patients with generalized anxiety disorder showed greater anticipatory activity than healthy comparison subjects in the bilateral dorsal amygdala preceding both aversive and neutral pictures. Building on prior reports of pretreatment anterior cingulate cortex activity predicting treatment response, anticipatory activity in that area was associated with clinical outcome 8 weeks later following treatment with venlafaxine. Higher levels of pretreatment anterior cingulate cortex activity in anticipation of both aversive and neutral pictures were associated with greater reductions in anxiety and worry symptoms. CONCLUSIONS: These findings of heightened and indiscriminate amygdala responses to anticipatory signals in generalized anxiety disorder and of anterior cingulate cortex associations with treatment response provide neurobiological support for the role of anticipatory processes in the pathophysiology of generalized anxiety disorder.
Authors: K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey Journal: Arch Gen Psychiatry Date: 2001-11
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: D Pizzagalli; R D Pascual-Marqui; J B Nitschke; T R Oakes; C L Larson; H C Abercrombie; S M Schaefer; J V Koger; R M Benca; R J Davidson Journal: Am J Psychiatry Date: 2001-03 Impact factor: 18.112
Authors: Jack B Nitschke; Christine L Larson; Marian J Smoller; Sarah D Navin; Adrian J C Pederson; Dante Ruffalo; Kristen L Mackiewicz; Shannon M Gray; Elise Victor; Richard J Davidson Journal: Psychophysiology Date: 2002-03 Impact factor: 4.016
Authors: Karina S Blair; Marilla Geraci; Bruce W Smith; Nick Hollon; Jeffrey DeVido; Marcela Otero; James R Blair; Daniel S Pine Journal: Biol Psychiatry Date: 2012-05-15 Impact factor: 13.382
Authors: Matthew Garner; Angela Attwood; David S Baldwin; Alexandra James; Marcus R Munafò Journal: Neuropsychopharmacology Date: 2011-04-13 Impact factor: 7.853
Authors: Pengfei Xu; Ruolei Gu; Lucas S Broster; Runguo Wu; Nicholas T Van Dam; Yang Jiang; Jin Fan; Yue-jia Luo Journal: J Neurosci Date: 2013-11-20 Impact factor: 6.167
Authors: Jacqueline A Clauss; Suzanne N Avery; Ross M VanDerKlok; Baxter P Rogers; Ronald L Cowan; Margaret M Benningfield; Jennifer Urbano Blackford Journal: Depress Anxiety Date: 2014-04-17 Impact factor: 6.505
Authors: Richard J Macatee; Nicholas P Allan; Agnieszka Gajewska; Aaron M Norr; Amanda Medley Raines; Brian J Albanese; Joseph W Boffa; Norman B Schmidt; Jesse R Cougle Journal: Cognit Ther Res Date: 2015-08-15
Authors: Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay Journal: Annu Rev Clin Psychol Date: 2013 Impact factor: 18.561